ETON
Eton Pharmaceuticals Inc

5,616
Mkt Cap
$440.08M
Volume
144,303.00
52W High
$23.00
52W Low
$11.09
PE Ratio
-65.88
ETON Fundamentals
Price
$16.79
Prev Close
$16.41
Open
$16.56
50D MA
$17.90
Beta
0.76
Avg. Volume
330,808.63
EPS (Annual)
-$0.1476
P/B
19.03
Rev/Employee
$1.26M
Loading...
Loading...
News
all
press releases
What is HC Wainwright's Estimate for ETON FY2025 Earnings?
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Investment analysts at HC Wainwright cut their FY2025 earnings per share estimates for Eton Pharmaceuticals in a research report issued on...
MarketBeat·9h ago
News Placeholder
More News
News Placeholder
Q4 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Research analysts at HC Wainwright cut their Q4 2026 EPS estimates for Eton Pharmaceuticals in a note issued to investors on Tuesday, December...
MarketBeat·1d ago
News Placeholder
Divisadero Street Capital Management LP Purchases New Holdings in Eton Pharmaceuticals, Inc. $ETON
Divisadero Street Capital Management LP acquired a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·3d ago
News Placeholder
Divisadero Street Capital Management LP Purchases New Holdings in Eton Pharmaceuticals, Inc. $ETON
Divisadero Street Capital Management LP acquired a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·3d ago
News Placeholder
Geode Capital Management LLC Has $8.45 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON
Geode Capital Management LLC increased its position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 98.8% in the 2nd quarter, according to the company in its most recent filing...
MarketBeat·6d ago
News Placeholder
Diametric Capital LP Increases Stock Holdings in Eton Pharmaceuticals, Inc. $ETON
Diametric Capital LP lifted its position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 333.0% in the 2nd quarter, according to its most recent filing with the Securities...
MarketBeat·6d ago
News Placeholder
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Investors need to pay close attention to ETON stock based on the movements in the options market lately.
Zacks·7d ago
News Placeholder
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Investors need to pay close attention to ETON stock based on the movements in the options market lately.
Zacks·7d ago
News Placeholder
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Investors need to pay close attention to ETON stock based on the movements in the options market lately.
Zacks·7d ago
News Placeholder
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Consensus Rating of "Hold" from Analysts
Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) have received a consensus recommendation of "Hold" from the five research firms that are presently covering the stock...
MarketBeat·12d ago

Latest ETON News

View

Advertisement|Remove ads.

Advertisement|Remove ads.